W.K. Berry

764 total citations
15 papers, 567 citations indexed

About

W.K. Berry is a scholar working on Pharmacology, Plant Science and Molecular Biology. According to data from OpenAlex, W.K. Berry has authored 15 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 6 papers in Plant Science and 5 papers in Molecular Biology. Recurrent topics in W.K. Berry's work include Cholinesterase and Neurodegenerative Diseases (8 papers), Pesticide Exposure and Toxicity (6 papers) and Computational Drug Discovery Methods (4 papers). W.K. Berry is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (8 papers), Pesticide Exposure and Toxicity (6 papers) and Computational Drug Discovery Methods (4 papers). W.K. Berry collaborates with scholars based in Slovenia, United Kingdom and United States. W.K. Berry's co-authors include L. Austin, D. R. Davies, C. Lovatt Evans, J Gordon, P. J. Fraser, A Todrick and M. P. Maidment and has published in prestigious journals such as Nature, Biochemical Pharmacology and Journal of Pharmacy and Pharmacology.

In The Last Decade

W.K. Berry

14 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W.K. Berry Slovenia 9 378 247 173 115 92 15 567
Joseph H. Fleisher United States 14 336 0.9× 401 1.6× 174 1.0× 47 0.4× 170 1.8× 37 722
Sigrun H. Sterri Norway 16 263 0.7× 384 1.6× 163 0.9× 63 0.5× 153 1.7× 22 732
Margaret G. Filbert United States 13 189 0.5× 202 0.8× 174 1.0× 33 0.3× 76 0.8× 28 498
J. H. Wills United States 14 156 0.4× 200 0.8× 100 0.6× 18 0.2× 68 0.7× 36 523
B.P. Doctor United States 8 384 1.0× 230 0.9× 162 0.9× 190 1.7× 40 0.4× 11 484
Richard P. Solana United States 11 208 0.6× 261 1.1× 46 0.3× 59 0.5× 78 0.8× 16 373
Anders Sundwall Sweden 13 170 0.4× 146 0.6× 152 0.9× 11 0.1× 55 0.6× 24 442
M. B. Abou-Donia United States 16 132 0.3× 359 1.5× 131 0.8× 20 0.2× 81 0.9× 37 730
Mary C. French United Kingdom 11 180 0.5× 260 1.1× 66 0.4× 15 0.1× 108 1.2× 17 404
Judith L. Engel United States 15 84 0.2× 315 1.3× 185 1.1× 14 0.1× 178 1.9× 18 873

Countries citing papers authored by W.K. Berry

Since Specialization
Citations

This map shows the geographic impact of W.K. Berry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.K. Berry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.K. Berry more than expected).

Fields of papers citing papers by W.K. Berry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W.K. Berry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.K. Berry. The network helps show where W.K. Berry may publish in the future.

Co-authorship network of co-authors of W.K. Berry

This figure shows the co-authorship network connecting the top 25 collaborators of W.K. Berry. A scholar is included among the top collaborators of W.K. Berry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W.K. Berry. W.K. Berry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Berry, W.K., et al.. (1971). Choline ester hydrolases in diaphragm muscle. Biochemical Pharmacology. 20(3). 669–682. 9 indexed citations
2.
Berry, W.K.. (1971). Acceleration by free carbamate of the spontaneous reactivation of carbamylated acetylcholinesterase. Biochemical Pharmacology. 20(11). 3236–3238. 6 indexed citations
5.
Berry, W.K. & D. R. Davies. (1970). The use of carbamates and atropine in the protection of animals against poisoning by 1,2,2-trimethylpropyl methylphosphonofluoridate. Biochemical Pharmacology. 19(3). 927–934. 162 indexed citations
6.
Berry, W.K. & M. P. Maidment. (1970). Pharmacological actions of pralidoxime in relation to therapeutic doses. Journal of Pharmacy and Pharmacology. 22(5). 379–379. 1 indexed citations
7.
Berry, W.K., et al.. (1966). Problems in the treatment with oximes and atropine of rats poisoned by organophosphates. Biochemical Pharmacology. 15(9). 1259–1266. 8 indexed citations
8.
Berry, W.K.. (1960). Cholinesterases in human serum. Biochimica et Biophysica Acta. 39(2). 346–348. 19 indexed citations
9.
Berry, W.K., et al.. (1959). OXIMES OF αω‐DIQUATERNARY ALKANE SALTS AS ANTIDOTES TO ORGANOPHOSPHATE ANTICHOLINESTERASES. British Journal of Pharmacology and Chemotherapy. 14(2). 186–191. 13 indexed citations
10.
Berry, W.K.. (1956). Phospholipid Metabolism of Skin. Nature. 177(4513). 789–790. 4 indexed citations
11.
Berry, W.K., et al.. (1955). The in vitro protection of cholinesterases against some organophosphorus inhibitors. Biochemical Journal. 59(1). 1–5. 8 indexed citations
12.
Austin, L. & W.K. Berry. (1953). Two selective inhibitors of cholinesterase. Biochemical Journal. 54(4). 695–700. 281 indexed citations
13.
Berry, W.K.. (1953). Appendix—A note on the reaction with inhibitors of enzymes which are inhibited by excess substrate. Biochemical Journal. 54(4). 700–701. 3 indexed citations
14.
Berry, W.K.. (1951). The turnover number of cholinesterase. Biochemical Journal. 49(5). 615–620. 21 indexed citations
15.
Berry, W.K. & C. Lovatt Evans. (1951). Cholinesterase and neuromuscular block.. PubMed. 115(1). 46–7 P. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026